🔗 Visit the ClinicalTrials.gov page for NCT01523977
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies. | Front Oncol | 2014 | 1.03 |
| 2 | Novel agents for the treatment of childhood acute leukemia. | Ther Adv Hematol | 2015 | 0.87 |
| 3 | Targeting mTOR for the treatment of B cell malignancies. | Br J Clin Pharmacol | 2016 | 0.85 |
| 4 | Molecular therapeutic approaches for pediatric acute myeloid leukemia. | Front Oncol | 2014 | 0.83 |
| 5 | Targeted drug discovery for pediatric leukemia. | Front Oncol | 2013 | 0.82 |
| 6 | Dissecting the PI3K Signaling Axis in Pediatric Solid Tumors: Novel Targets for Clinical Integration. | Front Oncol | 2013 | 0.79 |
| 7 | Advances in paediatric cancer treatment. | Transl Pediatr | 2014 | 0.76 |